Ademar Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.60 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 522.63%
- Profit Growth 63.35%
- Ebitda 65.77%
- Net Worth 161.19%
- Total Assets 171.09%
About Ademar Pharma
Ademar Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 April 2016 (Eight years and nine months 21 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Ambati Prasad, Sherifuddin Shaik, and Syed Ahmed serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100TG2016PTC109147
-
Company No.
109147
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Apr 2016
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ademar Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syed Ahmed
|
Director | 20-Apr-2016 | Current |
|
Ambati Prasad
|
Director | 26-Jul-2017 | Current |
|
Sherifuddin Shaik
|
Director | 20-Apr-2016 | Current |
Financial Performance of Ademar Pharma.
Ademar Pharma Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 522.63% increase. The company also saw a substantial improvement in profitability, with a 63.35% increase in profit. The company's net worth Soared by an impressive increase of 161.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ademar Pharma?
In 2018, Ademar Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Evertogen Life Sciences LimitedSherifuddin Shaik is a mutual person
-
Vidmed Health Technologies Private LimitedSherifuddin Shaik is a mutual person
-
Cb Agros And Shopping Malls Private LimitedAmbati Prasad is a mutual person
-
Siva Sindhu Agro Farms Private Limited
Ambati Prasad is a mutual person
-
Chirrayanam Agro Farms Private Limited
Ambati Prasad is a mutual person
-
Jishitha Agro Farms Private Limited
Ambati Prasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ademar Pharma?
Unlock and access historical data on people associated with Ademar Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ademar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ademar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.